Navigation Links
Differences between women and men with a primary psychotic episode analyzed in a Ph.D. thesis
Date:6/30/2010

This release is available in Spanish.

Schizophrenia is a heterogeneous disease, due to the fact that the reasons for its onset are varied, as are the reactions of patients who suffer from it. Some experts relieve that gender is an important factor in this heterogeneity. Ms Ana Cataln has presented her PhD thesis at the University of the Basque Country (UPV/EHU) on this topic, entitled Differences in the prognostic and clinical presentation as a function of gender amongst patients with a primary psychotic episode. She concluded that there are differences between men and women in this matter and that should be taken into account, but there is no evidence to suggest that sex totally conditions this illness.

In order to carry out her thesis, Ms Cataln designed an observational study and limited it to the primary psychotic episode. She analysed 231 patients, selected after establishing the criteria required thereof. For two years she studied the progress of these patients with a primary psychotic episode, evaluating gender solely as a biological feature, i.e. leaving aside its social and cultural connotations.

Later in women

Based on the observation of these patients, according to Ms Cataln, women with a primary psychotic episode in general show symptoms of the illness later and have a greater probability of being married and/or living with their partner and/or children. Moreover, in the case of women it is more common to suffer an acute form of psychosocial stress in the year prior to the onset of the illness. Also, on applying the Cannon-Spoor subscale, which measures the promorbid or prior to the illness adjustment, women obtain better results in late adolescence, adult age and in general. That is, during the lifetime previous to the onset of the first symptoms, appropriately complying with expectations in accord with each age range.

The author of the thesis also used the scale known as PANSS in order to analyse the clinical progress of the patients over the two years the research lasted; this scale is used to measure the gravity of the symptoms of patients with schizophrenia. As the scale shows, differences between the two sexes are, with an occasional exception, scant in the progress at the basal phase of the illness.

Thus, concluded Ms Cataln, the sex does not turn out to be a decisive prognostic factor in the progress of primary psychotic episodes. However, there are differences produced between men and women as regards the characteristics of the psychotic crisis episodes (clinical phenotype) and the author of the thesis underlines that these should be taken into consideration by the doctor.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. Chinese systemic lupus erythematosus data reveal differences in epidemiology across continents
2. Genealogy may affect clinical differences in systemic lupus erythmatosus patients
3. Vast geographic differences found in drug spending under Medicare
4. Survey highlights major Canada-US differences in people in middle age
5. Genetic differences may influence joint pain among women taking lifesaving breast cancer drugs
6. Regional differences in C-section rate not a result of maternal request: UBC study
7. Dyslexia Linked to Differences in Brain Circuitry
8. Population health plays a bigger role in geographic differences in Medicare spending
9. Exploring gender differences in colorectal cancer screenings
10. Differences in language circuits in the brain linked to dyslexia
11. Gender Differences Show in Risk of Narcotic Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... ... The Citadel’s new Swain Department of Nursing , along with its ... Joseph was engaged by the college as a consultant to help build the curriculum ... nation-wide search, she was selected to head the department as nurse administrator, assuming the ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 p.m. ... burden? Pay dividends in enhanced and predictable product performance? Streamline processes resulting ...
(Date:2/18/2017)... ... 18, 2017 , ... ProParagraph Fashion Volume 2 features 30 ... Fashion Volume 2 for all multi-line FCPX project needs. Great for website ... choose from hand-crafted trend-setting designs with smooth animations that will add stylistic flare ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... allow for the electronic prescribing of controlled and non-controlled substances plus the ability ... of pharmacies in the United States now accept electronic prescriptions, according to the ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum Awards ... healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, highlighting ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 20, 2017 According to a new market research ... powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End ... The market is projected to reach USD 52.37 Billion by 2021 from ... forecast period. Continue Reading ... ...
(Date:2/20/2017)... -- Acute, Chronic and Prophylaxis GVHD The global ... of 7% from 2016-2021 and CAGR of 3% from 2021-2027. The market ... 2027. The market is estimated at $0.36bn in 2016, $0.51bn in 2021, ... How ... can exploit the future business opportunities emerging in this sector. ...
(Date:2/19/2017)... and ORLANDO, Fla. , ... NKTR ) today announced that positive Phase 1 ... patients with renal cell carcinoma (RCC) were presented at ... designed to expand specific cancer-fighting T cells and Natural ... and increase expression of PD-1 on these immune cells.  ...
Breaking Medicine Technology: